Home > Clinical Trials

Saved trials

COMPLETED
NCT03996772
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
319 Enrollment(s)
64 Study location(s)
INTERVENTIONAL (PHASE3)
Atrial Fibrillation


Intracerebral Hemorrhage
ACTIVE_NOT_RECRUITING
NCT03950076
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
948 Enrollment(s)
152 Study location(s)
INTERVENTIONAL (PHASE4)
Intracranial Hemorrhages


Atrial Fibrillation
COMPLETED
NCT03523572
Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
86 Enrollment(s)
29 Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer


Urothelial Carcinoma
RECRUITING
NCT03127631
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
6,000 Enrollment(s)
54 Study location(s)
INTERVENTIONAL (NA)
Prostate Cancer


Cardiovascular Disease
COMPLETED
NCT02834390
Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
7 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Acute Myeloid Leukemia
COMPLETED
NCT02798471
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
290 Enrollment(s)
140 Study location(s)
INTERVENTIONAL (PHASE3)
Venous Thromboembolism (VTE)


Pulmonary Embolism


Deep Vein Thrombosis (DVT)
TERMINATED
NCT02618577
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
2,608 Enrollment(s)
18 Study location(s)
INTERVENTIONAL (PHASE3)
Atrial High Rate Episodes
COMPLETED
NCT02401815
CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
51 Enrollment(s)
6 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Gastrointestinal Stromal Tumors